跳至主要内容
临床试验/NCT01558622
NCT01558622Unknown4 期

Intraoperative Use of Dexketoprofen Trometamol, Tramadol Hcl, Pethidine Hcl and Their Combinations for Postoperative Pain Management in Laparoscopic Nissen Fundoplication

Kavaklıdere Umut Hospital1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2012年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
72
试验地点
1
主要终点
Allergic reactions to NSAIDs or opioid analgesics, body mass index exceeding 35

研究概览

简要总结

The purpose of this study is to evaluate the analgesic effects of dexketoprofen trometamol, tramadol hydrochloride, pethidine hydrochloride and their combinations in laparoscopic Nissen fundoplication.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 18-60 years old ASA I-II patients
  • Clinical diagnosis of gastroesophageal reflux patients

排除标准

  • Allergic reactions to NSAIDs or opioid analgesics
  • Body mass index exceeding 35
  • Pregnancy

研究组 & 干预措施

dexketoprofen trometamol

Placebo Comparator

Dexketoprofen trometamol is a water-soluble salt of the dextrorotatory enantiomer of the nonsteroidal anti-inflammatory drug (NSAID) ketoprofen.

干预措施: dexketoprofen trometamol (Drug)

tramadol hydrochloride

Placebo Comparator

Tramadol Hydrochloride is a well-known centrally acting opioid pain killer.

干预措施: tramadol hydrochloride (Drug)

pethidine hydrochloride

Placebo Comparator

Pethidine is a synthetic opioid analgesic which produces a pattern of effects similar to morphine the standard against which opioid analgesics are compared.

干预措施: pethidine hydrochloride (Drug)

dexketoprofen trometamol + tramadol hydrochloride

Placebo Comparator

干预措施: dexketoprofen trometamol + tramadol hydrochloride (Drug)

dexketoprofen trometamol + pethidine hydrochloride

Placebo Comparator

干预措施: dexketoprofen trometamol + pethidine hydrochloride (Drug)

vitamin c

Placebo Comparator

干预措施: vitamin c (Drug)

结局指标

主要结局

Allergic reactions to NSAIDs or opioid analgesics, body mass index exceeding 35

时间窗: postoperative 2 hours

次要结局

未报告次要终点

研究者

发起方
Kavaklıdere Umut Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

GOKHAN GOKMEN

Anesthesiologist, MD

Kavaklıdere Umut Hospital

研究点 (1)

Loading locations...

相似试验